241 related articles for article (PubMed ID: 27570126)
1. Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics.
Chang KM; Liu M
Curr Opin Pharmacol; 2016 Oct; 30():93-105. PubMed ID: 27570126
[TBL] [Abstract][Full Text] [Related]
2. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
Meng Z; Chen Y; Lu M
Front Immunol; 2019; 10():3127. PubMed ID: 32117201
[TBL] [Abstract][Full Text] [Related]
3. Advances in therapeutics for chronic hepatitis B.
Yang N; Bertoletti A
Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
[TBL] [Abstract][Full Text] [Related]
4. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
Koh S; Bertoletti A
Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
[TBL] [Abstract][Full Text] [Related]
5. Interferon and Hepatitis B: Current and Future Perspectives.
Ye J; Chen J
Front Immunol; 2021; 12():733364. PubMed ID: 34557195
[TBL] [Abstract][Full Text] [Related]
6. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.
Chen J; Yuan Z
Virol Sin; 2014 Feb; 29(1):17-24. PubMed ID: 24452540
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
Gao Y; Zhang TY; Yuan Q; Xia NS
Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of Hepatitis B Virus.
Tseng TC; Huang LR
J Infect Dis; 2017 Nov; 216(suppl_8):S765-S770. PubMed ID: 29156047
[TBL] [Abstract][Full Text] [Related]
9. Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?
Bertoletti A; Gehring AJ
PLoS Pathog; 2013; 9(12):e1003784. PubMed ID: 24367255
[No Abstract] [Full Text] [Related]
10. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
Zhu W; Liu H; Zhang X
ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into immunotherapy for hepatitis B patients.
Akbar SM; Al-Mahtab M; Jahan M; Yoshida O; Hiasa Y
Expert Rev Gastroenterol Hepatol; 2016; 10(2):267-76. PubMed ID: 26626120
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Chronic Hepatitis B Virus Infection.
Bertoletti A; Le Bert N
Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
[TBL] [Abstract][Full Text] [Related]
13. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
Bertoletti A; Ferrari C
Gut; 2012 Dec; 61(12):1754-64. PubMed ID: 22157327
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
Wang L; Zou ZQ; Liu CX; Liu XZ
J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
Lobaina Y; Michel ML
Vaccine; 2017 Apr; 35(18):2308-2314. PubMed ID: 28351734
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of hepatitis B virus infection and potential for new therapies.
Peppa D; Maini MK
Br J Hosp Med (Lond); 2012 Oct; 73(10):581-4. PubMed ID: 23124289
[TBL] [Abstract][Full Text] [Related]
17. Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.
Gehring AJ; Protzer U
Gastroenterology; 2019 Jan; 156(2):325-337. PubMed ID: 30367834
[TBL] [Abstract][Full Text] [Related]
18. Immunopathogenesis of chronic hepatitis B.
Balmasova IP; Yushchuk ND; Mynbaev OA; Alla NR; Malova ES; Shi Z; Gao CL
World J Gastroenterol; 2014 Oct; 20(39):14156-71. PubMed ID: 25339804
[TBL] [Abstract][Full Text] [Related]
19. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.
Akbar SM; Al-Mahtab M; Khan MS
Expert Opin Biol Ther; 2013 Jul; 13(7):1063-74. PubMed ID: 23581572
[TBL] [Abstract][Full Text] [Related]
20. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
